ESG News For Illumina, Inc.

Over the last 20 years, precision medicine has become the standard of care, but for many hospitals, the complexity of the process has made it challenging to integrate or manage efficiently and at scale.

Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact benchtop sequencers that incorporate more than 140 invention disclosures and 60 patent families. Through a series of News Center articles, we are celebrating outstanding employees.

The platypus is a venomous mammal that lays eggs, can sense electricity, and has 10 sex chromosomes. The tuatara is a reptile from a lineage that evolved before most dinosaurs (and all lizards). The bluehead wrasse is a fish that can change sex.

How would it feel to know the work you do each day is impacting human health on a global scale? As genomics enables a new era of heath care, Illumina technology is empowering personalized care – improving health outcomes for all.

Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact benchtop sequencers that incorporate more than 140 invention disclosures and 60 patent families. On our News Center, we are celebrating outstanding employees who helped develop this tech.

The Leukemia & Lymphoma Society estimates that by year end, 2024 will have seen 187,740 Americans diagnosed with a blood cancer—or about one person every three minutes.

Illumina Vice President of Bioinformatics James Han has been in the industry for decades—so he’s witnessed every stride the company has made in that time. “Illumina has worked tirelessly for the last 20 years to improve sequencing,” he says.

A large, multiyear study conducted by Illumina, Providence, and Microsoft Research has shown that a comprehensive genomic profiling (CGP) panel, which can assess more than 500 genetic variations in tumors, is a powerful tool to direct patients to advanced precision therapy.

Illumina employees have been showing their commitment to early cancer detection and advancing research and treatment by getting involved in the company’s recently concluded Steps Against Cancer campaign.

The Human Genome Project described the first (almost) complete reference genome, but it didn’t say much about human variation. For that, scientists had to conduct massive population genomics (pop gen) studies, sequencing millions of people.

For the second year in a row, Illumina’s Singapore team participated in the annual overnight Relay for Life Charity Run for the Singapore Cancer Society (SCS). Starting in the early evening on April 20, about 40 employees took to the track, and they completed 125 kilometers.

The Next-Generation Sequencing Core in the Washington, DC, Public Health Laboratory (PHL) has a critical job: pathogen surveillance for the nation’s capital. A team of scientists is trying to understand the molecular underpinnings that drive foodborne illnesses.

As you read this, a white box the size of a refrigerator is hurtling through space at 17,500 miles per hour (28,000 kph), shooting four lasers at the Earth 242 times a second. It’s called the Global Ecosystem Dynamics Investigation sensor, or GEDI.

Karina Katalina Moreno has taken a circuitous route to her American dream. She grew up in Monterrey, Mexico, about 140 miles (225 km) south of Laredo, Texas, and got her degree in biotech engineering at Tecnológico de Monterrey.

What happens when you combine the power of genomics with the dedication of citizen scientists at scale? You create powerful datasets to understand and improve the health of our world’s oceans.

What if one thing could change everything for the better? That’s genomics. At Illumina, our vision for the future includes accessibility to genome sequencing, personalized medicine, and more positive outcomes for those facing disease.

Samantha Goldbaum, age 16, runs a STEM club at her charter high school in Chula Vista, California, 7.5 miles from the US-Mexico border. The club, and her school, are both very small, and she finds it difficult to share her interest in science with others in her community.

You’ll find domestic cattle nearly everywhere on Earth, but they won’t always look like the milk-carton mascots you’re probably familiar with. Especially on family-owned farms and in small herds, cattle breeds can differ greatly depending on their region.

This year may be the most impactful yet in the short history of iHope China. In Changsha, Hunan Province, the program’s leaders recently announced plans to deepen its impact by increasing reagent donations and expanding its coverage area.

Illumina ranks 5th overall and is the top-ranking company in the U.S. and the biotechnology industry in TIME’s ‘World's Most Sustainable Companies 2024’ list. The list ranks the top 500 companies out of more than 3,000 reviewed.

Every person at Illumina has the chance to make a difference, and we recently sat down with four of our colleagues to learn how their individual contributions have added up to create extraordinary results.

What if the work you did every day could impact the lives of people you know? Or all of humanity? At Illumina, we believe that, together, we can use genomics to build a stronger world for the greater good.

Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today published its fifth annual Corporate Social Responsibility (CSR) Report.

On April 25, Illumina opened its doors in Granta Park, Cambridge, to celebrate DNA Day. This annual event marks a significant milestone in the history of science: the successful completion of the Human Genome Project in 2003 and the groundbreaking discovery of DNA’s double helix.

Inside a lab that is off-limits to most employees, Staff Engineer Allie Duchnak coordinates hundreds of details for highly confidential projects. Based at Illumina’s San Diego headquarters, her interdisciplinary team, Advanced Platforms, builds test beds for components.

A recent literature review, published in the Nature journal Genomic Medicine, showed that short-read genomic sequencing (GS) reduces the time it takes to diagnose and treat pediatric patients who may have a rare genetic condition.

Whole-genome sequencing (WGS) use is more established for rare and pediatric disease, but next-generation sequencing in clinical use for cancer consists of various approaches.

Next-generation sequencing (NGS) provides amazing insights into health care, agriculture, food safety, and many other disciplines, making it increasingly essential for students to have access to this technology to enhance their career options.

In the early days of the pandemic, personal and professional aspects of Carlos D. Bustamante’s life were converging. His daughter had just fallen ill with a post-infectious condition at a time when he was partnering with a team at Stanford University.

When scientists want to sequence a DNA sample on an Illumina system, they don’t try to read all 4 billion base pairs of the genome at once. Instead, they slice the DNA into short fragments of about 500 base pairs that are easier to work with and faster to read.

The United Nations projects that the total human population will exceed 9 billion by 2040. Feeding that many people will demand advances in sustainable farming, especially in aquaculture.

For the fifth year in a row, Illumina has been named one of America’s Most JUST Companies by JUST Capital and CNBC. Illumina ranked #29, out of the top 100, and second in the pharmaceutical and biotech industry.

Collaboration Will Continue to Raise Awareness of the Galleri® Multi-Cancer Early Detection Test, a New Proactive Tool in Finding Cancer EarlierPortion of Galleri Classic Proceeds Will be Directed to Local Cancer-related Nonprofit Organizations Focused on Underserved Populations in the Coachella Valley

Call it archaeology by other means. Rather than sifting through tons of dirt and carefully cataloguing human artifacts, Eske Willerslev and his colleagues have used Illumina NovaSeq Systems to sequence 5000 ancient human genomes, revealing previously unseen historical nuance.

The San Diego Zoo cares for the largest population of koalas outside Australia. The zoo is world renowned for its specialized veterinary care and decades-long commitment to wildlife conservation work, and one of the biggest challenges their koala population faces is koala KoRV.

Nucleus Genomics is realizing the dream set into motion long ago by the Human Genome Project: to use the power of genomics to help people live lives that are as healthy and long as possible.

Methane is 28 times more powerful a greenhouse gas than carbon dioxide: It’s responsible for a third of global warming. A single cow can produce up to 500 liters of methane a day, or 160 kilograms per year, mostly through eructation (that is, belching).

Illumina has been named to the Dow Jones Sustainability World Index and the North America Index for 2023 in the Life Sciences Tools & Services Industry. This is the fifth consecutive year the company has been named to the prestigious list.

Breast Cancer Canada has launched Progress CONNECT, a new portal equipping Canadian breast cancer patients to know more about their individual cancer type, options and treatment

Hundreds of global leaders will convene during the two-day event to highlight the important role connection plays in addressing global challenges

Finalist round will judge for clinical validation in competition aimed at developing frequent, fast, affordable, and easy-to-use COVID-19 tests, easing global supply chain

The North Carolina Biotechnology Center, City of Burlington, LabCorp, Alamance Community College and Illumina will partner to train local talent for new bioscience jobs